Luage, Maria Luz .

HRN: 22-47-23  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2023
CO-AMOXICLAV 625MG (TAB)
01/12/2023
01/19/2023
ORAL
625
BID
Nka
Waiting Final Action 
01/13/2023
CEFUROXIME 1.5GM (VIAL)
01/13/2023
01/20/2023
IV
1.5g
Q8
Abortion
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: